- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: recombinant human interleukin-2 (rhIL-2)
Total 973 results
-
Chiesi Farmaceutici S.p.A.ICON plcRecruiting
-
University of EdinburghNovartis Pharmaceuticals; NHS LothianCompleted
-
Celularity IncorporatedCompleted
-
Roswell Park Cancer InstituteActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian Carcinoma | Platinum-Sensitive Ovarian Carcinoma | Refractory Ovarian... and other conditionsUnited States
-
RevimmuneWashington University School of Medicine; University Hospital, Limoges; George...TerminatedSepsis, SevereUnited States, France
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Switzerland, Canada, Netherlands, Puerto Rico, Australia
-
NCIC Clinical Trials GroupZymoGeneticsCompletedMelanoma (Skin)Canada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingGenetically Modified T-Cells Followed by Aldesleukin in Treating Patients With Stage III-IV MelanomaMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
M.D. Anderson Cancer CenterCompletedRecurrent Synovial Sarcoma | HLA-A*0201 Positive Cells Present | NY-ESO-1 Positive Tumor Cells Present | Recurrent Myxoid LiposarcomaUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)Active, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
University of Michigan Rogel Cancer CenterUniversity of MichiganTerminated
-
University Health Network, TorontoMerck Sharp & Dohme LLCCompletedAdvanced Ovarian Cancer | Malignant MelanomaCanada
-
Beijing YouAn HospitalUnknownHepatocellular CarcinomaChina
-
Apeiron BiologicsCompletedCOVID-19Denmark, Germany, Austria, Russian Federation, United Kingdom
-
Acorda TherapeuticsCompleted
-
Sanofi Pasteur, a Sanofi CompanyGlaxoSmithKlineCompletedCOVID-19Honduras, United States, Australia, France, New Zealand, Spain, United Kingdom
-
Loma Linda UniversityWithdrawnMelanoma | Metastatic Kidney CancerUnited States
-
University of ChicagoNational Cancer Institute (NCI)Completed
-
Washington University School of MedicineNational Cancer Institute (NCI); American Society of Clinical Oncology; ImmunityBio... and other collaboratorsTerminatedLeukemia, Myeloid, AcuteUnited States
-
Virginia Commonwealth UniversityAmerican Heart AssociationCompletedHeart FailureUnited States
-
University of ChicagoCompletedMetastatic MelanomaUnited States
-
University Hospital, BordeauxCompletedAutoimmune Hemolytic AnemiaFrance
-
Medtronic Spinal and BiologicsCompleted
-
Assistance Publique - Hôpitaux de ParisIltoo PharmaCompletedRecurrent MiscarriageFrance
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedNeuroblastomaUnited States, Canada
-
National Institute of Allergy and Infectious Diseases...CompletedCutaneous LeishmaniasisUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Recurrent Childhood Acute Myeloid Leukemia | Therapy-Related Acute Myeloid Leukemia | Donor | Hematopoietic Cell Transplant Recipient | HLA-A*0201 Positive Cells PresentUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)Completed
-
French National Agency for Research on AIDS and...Chiron CorporationCompleted
-
Fred Hutchinson Cancer Research Center/University...National Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV MelanomaUnited States
-
Beijing YouAn HospitalUnknownHepatocellular CarcinomaChina
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)TerminatedMetastatic Malignant Neoplasm in the Brain | Metastatic Malignant Neoplasm | HLA-A2 Positive Cells PresentUnited States
-
Peking University Cancer Hospital & InstituteCompletedBreast Neoplasms | Neoplasm Metastasis | Immunotherapy | Gene Expression ProfilingChina
-
King's College LondonKing's College Hospital NHS TrustTerminatedLiver Diseases | TransplantationUnited Kingdom
-
NYU Langone HealthNational Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
VicalNational Cancer Institute (NCI); Jonsson Comprehensive Cancer CenterTerminatedProstate CancerUnited States
-
Lee's Pharmaceutical LimitedNot yet recruiting
-
Peking University People's HospitalUnknown
-
Hellenic Institute for the Study of SepsisCompletedSepsis | Macrophage Activation SyndromeGreece
-
National Cancer Institute (NCI)CompletedHigh Risk NeuroblastomaUnited States
-
VicalNational Cancer Institute (NCI); Jonsson Comprehensive Cancer CenterTerminated
-
Cambridge University Hospitals NHS Foundation TrustNot yet recruitingCarotid Artery Plaque | Carotid Atherosclerosis | TIAUnited Kingdom
-
Abramson Cancer Center of the University of PennsylvaniaWithdrawnOvarian, Fallopian Tube and Peritoneal CancerUnited States
-
St. Louis UniversityMajor Extremity Trauma Research ConsortiumTerminated
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMetastatic Melanoma | Stage IV Cutaneous Melanoma AJCC v6 and v7United States
-
Icahn School of Medicine at Mount SinaiCompletedCommon Variable Immunodeficiency
-
Aalborg University HospitalUnknownHIV Infections | Hepatitis B | Hepatitis ADenmark
-
Astellas Pharma Global Development, Inc.CompletedCLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction | CLDN18.2-positive Adenocarcinoma of Esophagus | CLDN18.2-positive Gastric AdenocarcinomaGermany, Latvia